AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionCalton & Associates, Inc.
Latest Disclosed Ownership6,419 shares
Latest Disclosed Value $ 1,396,063
Calton & Associates, Inc. reports 11.22% decrease in ownership of 4AB / AbbVie Inc.

On May 13, 2026 - Calton & Associates, Inc. filed a 13F-HR form disclosing ownership of 6,419 shares of AbbVie Inc. (BG:4AB) valued at $1,396,063 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 7,230 shares of AbbVie Inc.. This represents a change in shares of -11.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBVIE COM 00287Y109 6,419 -811 -11.22 1,396 -15.45 0.2006
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 7,230 179 2.54 1,652 1.16 0.2426
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 7,051 1,194 20.39 1,633 50.14 0.2451
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 5,857 -319 -5.17 1,087 -15.93 0.1880
2025-05-15 2025-03-31 13F/A-1 ABBVIE COM 00287Y109 6,176 2,615 73.43 1,294 104.59 0.2951
2025-05-05 2025-03-31 13F ABBVIE COM 00287Y109 1,800 -1,761 239 0.0544
2025-01-23 2024-12-31 13F ABBVIE COM 00287Y109 3,561 -847 -19.22 633 -27.36 0.2797
2024-10-21 2024-09-30 13F/A-1 ABBVIE COM 00287Y109 4,408 804 22.31 871 40.78 0.3327
2024-10-18 2024-09-30 13F ABBVIE COM 00287Y109 4,409 805 871 0.3387
2024-07-19 2024-06-30 13F ABBVIE COM 00287Y109 3,604 -383 -9.61 618 -14.76 0.3094
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 3,987 -979 -19.71 726 -5.72 0.3538
2024-02-07 2023-12-31 13F ABBVIE COM 00287Y109 4,966 2,393 93.00 770 100.78 0.3096
2023-11-01 2023-09-30 13F ABBVIE COM 00287Y109 2,573 -2,291 -47.10 384 -41.53 0.5607
2023-07-24 2023-06-30 13F ABBVIE COM 00287Y109 4,864 -69 -1.40 655 -16.67 0.3056
2023-04-19 2023-03-31 13F ABBVIE COM 00287Y109 4,933 61 1.25 786 -0.13 0.3647
2023-01-18 2022-12-31 13F ABBVIE COM 00287Y109 4,872 681 16.25 787 40.04 0.3047
2022-10-31 2022-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 4,191 -251 -5.65 562 -17.35 0.3219
2022-07-12 2022-06-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 4,442 -1,132 -20.31 680 -24.70 0.3780
2022-04-26 2022-03-31 13F/A-1 ABBVIE INC COM USD0.01 COM 00287Y109 5,574 -665 -10.66 903 6.99 0.2683
2022-04-12 2022-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 5,574 -665 903 0.2693
2022-01-13 2021-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 6,239 -2,579 -29.25 844 -11.25 0.2252
2021-11-05 2021-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 8,818 -776 -8.09 951 -12.27 0.2082
2021-08-11 2021-06-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 9,594 -944 -8.96 1,084 -4.91 0.2059
2021-05-03 2021-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 10,538 -8,998 -46.06 1,140 -45.53 0.2219
2021-01-25 2020-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 19,536 -5,589 -22.24 2,093 -4.91 0.3735
2020-10-30 2020-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 25,125 1,623 6.91 2,201 -4.59 0.4520
2020-08-10 2020-06-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 23,502 13,688 139.47 2,307 208.42 0.5026
2020-04-30 2020-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 9,814 -109 -1.10 748 -14.90 0.1852
2020-02-03 2019-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 9,923 3 0.03 879 17.04 0.1766
2019-11-07 2019-09-30 13F ABBVIE INC COM USD001 COM 00287Y109 9,920 633 6.82 751 11.26 0.1668
2019-07-09 2019-06-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 9,287 270 2.99 675 -7.15 0.1906
2019-04-25 2019-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 9,017 -1,005 -10.03 727 -21.32 0.2214
2019-02-11 2018-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 10,022 -2,571 -20.42 924 -22.42 0.3399
2018-10-24 2018-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 12,593 472 3.89 1,191 4.84 0.3505
2018-08-10 2018-06-30 13F ABBVIE INC COM USD001 COM 00287Y109 12,121 -10,940 -47.44 1,136 -47.96 0.3304
2018-04-17 2018-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 23,061 3,891 20.30 2,183 8.07 0.6318
2018-02-05 2017-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 19,170 19,170 2,020 0.5084
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.